1/9 🧵

Kudos to Millie Huang, MD candidate who completed her capstone project,
"Art and the Brain: Insights from Neurological Disorders." To understand the "brain wiring" and the creative process of painting, Millie Huang reviews the effects of neurological illness from stroke to Alzheimer's disease on the artist and their works of art.

youtu.be/JgXLfVMlTUA 2/9 🧵Millie Huang hails from Vancouver, Canada and completed her undergraduate studies at UPenn, studying #neuroscience and the classics. Millie Huang wrote a book chapter on the neuroscience of architecture, featured in the Women Writing Architecture collective. At Penn, she participated in the CNST med.upenn.edu/cnst/ summer program focused on immunotherapy in The Binder/O'Rourke Laboratory | She has a keen interest in child #Psychiatry, #Neurology, #Neurooncology, #Palliativecare and visual #Neuroscience.

Delighted that the Editorial Board of @NeurologyToday, the news source of the AAN, @AANmember, selected our dendritic cell vaccine trial, led by Dr. Linda Liau, as one of the "Best Advances of 2022." #immunotherapy @PennNeurology @PennNSG @PennCancer

pubmed.ncbi.nlm.nih.gov/36394838/ The article notes Median OS for 232 patients with nGBM on DCVax = 19.3M from randomization (22.4M from surgery) vs 16.5M from controls; Survival at 48 M = 15.7% vs 9.9%; mOS at 60M, 13.0M vs 5.7%. Survival for 64 patients with rGBM =13.2M vs. 7.8 M, controls. At 24M, 20.7 vs 9.6%

An urgent unmet need in neuro-oncology is a quantitative, non-invasive biomarker that can track and quantitate the heterogeneous, infiltrative, peritumoral microenvironment. Excited by the elegant, AI-based report of DiCIPHR Lab & CBICA, now in @SciReports
pubmed.ncbi.nlm.nih.gov/36653382/ Kudos to the authors, an interdisciplinary "Dream Team" from @PennRadiology, @PennNSG, engineering, informatics, working to advance the Penn Brain Tumor Center.